Advertisement

Characterization of basal hepatic bile flow and the effects of intravenous cholecystokinin on the liver, sphincter, and gallbladder in patients with sphincter of Oddi spasm

  • Gerbail T. KrishnamurthyEmail author
  • Shakuntala Krishnamurthy
  • Randy D. Watson
Original Article

Abstract

The major objectives of this project were to establish the pattern of basal hepatic bile flow and the effects of intravenous administration of cholecystokinin on the liver, sphincter of Oddi, and gallbladder, and to identify reliable parameters for the diagnosis of sphincter of Oddi spasm (SOS). Eight women with clinically suspected sphincter of Oddi spasm (SOS group), ten control subjects (control group), and ten patients who had recently received an opioid (opioid group) were selected for quantitative cholescintigraphy with cholecystokinin. Each patient was studied with 111–185 MBq (3–5 mCi) technetium-99m mebrofenin after 6–8 h of fasting. Hepatic phase images were obtained for 60 min, followed by gallbladder phase images for 30 min. During the gallbladder phase, 10 ng/kg octapeptide of cholecystokinin (CCK-8) was infused over 3 min through an infusion pump. Hepatic extraction fraction, excretion half-time, basal hepatic bile flow into the gallbladder, gallbladder ejection fraction, and post-CCK-8 paradoxical filling (>30% of basal counts) were identified. Seven of the patients with SOS were treated with antispasmodics (calcium channel blockers), and one underwent endoscopic sphincterotomy. Mean (±SD) hepatic bile entry into the gallbladder (versus GI tract) was widely variable: it was lower in SOS patients (32%±31%) than in controls (61%±36%) and the opioid group (61%±25%), but the difference was not statistically significant. Hepatic extraction fraction, excretion half-time, and pattern of bile flow through both intrahepatic and extrahepatic ducts were normal in all three groups. Gallbladder mean ejection fraction was 9%±4% in the opioid group; this was significantly lower (P<0.0001) than the values in the control group (54%±18%) and the SOS group (48%±29%). Almost all of the bile emptied from the gallbladder refluxed into intrahepatic ducts; it reentered the gallbladder after cessation of CCK-8 infusion (paradoxical gallbladder filling) in all eight patients with SOS, but in none of the patients in the other two groups. Mean paradoxical filling was 204% (±193%) in the SOS group and less than 5% (P<0.05) in both the control and the opioid group. After treatment, six of the SOS patients had complete pain relief and one, partial pain relief. The basal tonus of the sphincter is variable in patients with SOS, and allows relatively more of the hepatic bile to enter the GI tract than the gallbladder. Due to simultaneous contraction of the sphincter and gallbladder in response to CCK-8, most of the bile emptied from the gallbladder refluxes into intrahepatic ducts, and reenters the gallbladder immediately after cessation of hormone infusion. The characteristic features of gallbladder filling, emptying, and paradoxical refilling with cholecystokinin provide objective parameters for noninvasive diagnosis of SOS by quantitative cholescintigraphy.

Keywords

Sphincter of Oddi spasm Paradoxical gallbladder filling Hepatic bile flow Cholecystokinin Biliary dyskinesia 

Notes

Acknowledgements

The authors thank Mr. Bob Crummett, Tuality Community Hospital, Hillsboro, OR for preparation of Figs. 1, 2, and 3 and Dr. Dale Kraemer, Oregon Health and Sciences University. Portland, OR for providing statistical analysis.

References

  1. 1.
    Hogan WJ. Hepatobiliary scintigraphy as the diagnostic test for sphincter of Oddi dysfunction: pan the scan? Am J Gastroenterol 2002; 97:1288–1291.CrossRefPubMedGoogle Scholar
  2. 2.
    Geenen JE, Hogan WJ, Dodds WJ, Steward ET, Arndorfer RC. Intraluminal pressure recording from the human sphincter of Oddi. Gastroenterology 1980; 78:317–324.PubMedGoogle Scholar
  3. 3.
    Meshkinpour H, Mollot M, Eckerling GB, Brookman L. Bile duct dyskinesia. Clinical and manometric study. Gastroenterology 1984; 87:759–762.PubMedGoogle Scholar
  4. 4.
    Toouli J, Roberts-Thompson IC, Dent J, Lee J. Manometric disorders in patients with suspected sphincter of Oddi dysfunction. Gastroenterology 1985; 88:1243–1250.PubMedGoogle Scholar
  5. 5.
    Doo E, Krishnamurthy GT, Eklem MJ, Gilbert S, Brown PH. Quantification of hepatobiliary function as an integral part of imaging with technetium-99m mebrofenin in health and disease. J Nucl Med 1991; 32:48–57.PubMedGoogle Scholar
  6. 6.
    Krishnamurthy GT, Krishnamurthy S. Nuclear hepatology. A textbook of hepatobiliary diseases. New York, Berlin, Heidelberg: Springer, 2000.Google Scholar
  7. 7.
    Brown PH, Juni JE, Lieberman DA, Krishnamurthy GT. Hepatocyte versus biliary disease: a distinction by deconvolutional analysis of technetium-99m IDA time-activity curves. J Nucl Med 1988; 29:623–630.PubMedGoogle Scholar
  8. 8.
    Juni JE, Reichle R. Measurement of hepatocellular function with deconvolutional analysis: application in the differential diagnosis of acute jaundice. Radiology 1990; 177:171–175.PubMedGoogle Scholar
  9. 9.
    Krishnamurthy GT, Bobba VR, Kingston E. Radionuclide ejection fraction: a technique for quantitative analysis of motor function of the human gallbladder. Gastroenterology 1981; 80:482–490.PubMedGoogle Scholar
  10. 10.
    Krishnamurthy GT, Bobba VR, McConnell D, Turner FE, Mesgarzadeh M, Kingston E. Quantitative biliary dynamics: introduction of a new non-invasive scintigraphic technique. J Nucl Med 1983; 24:217–223.PubMedGoogle Scholar
  11. 11.
    Brar HS. Scintigraphic cholecystokinin-induced bile reflux named as Krishnamurthy-Bobba sign (letter to the editor). J Nucl Med 1990; 31:248.PubMedGoogle Scholar
  12. 12.
    Krishnamurthy GT, Krishnamurthy S. Hepatic bile entry into and transit pattern within the gallbladder lumen: introduction of a new quantitative cholescintigraphic technique for measurement of its concentration function. J Nucl Med 2002; 43:901–908.PubMedGoogle Scholar
  13. 13.
    Hogan WJ, Geenen JE. Biliary dyskinesia. Endoscopy 1988; 20:179–183.PubMedGoogle Scholar
  14. 14.
    Hogan WJ, Sherman S, Pasricha P, Carr-Locke D. American Motility Society. Position Paper. Sphincter of Oddi manometry. Gastrointest Endosc 1997; 45:342–348.PubMedGoogle Scholar
  15. 15.
    Thune A, Scicchitano J, Roberts-Thompson IC, Toouli J. Reproducibility of endoscopic sphincter of Oddi manometry. Dig Dis Sci 1991; 36:1401–1405.PubMedGoogle Scholar
  16. 16.
    Toouli J, Roberts-Thompson IC, Dent J, Lee J. Manometric disorders in patients with suspected sphincter of Oddi dysfunction. Gastroenterology 1985; 88:1243–1250.PubMedGoogle Scholar
  17. 17.
    Mutt V. Cholecystokinin: isolation, structure, and function. In: Glass GBJ, ed. Gastrointestinal hormones. New York: Raven Press; 1980:169–221.Google Scholar
  18. 18.
    Behar J, Biancani P. Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. J Clin Invest 1980; 66:1231–1239.PubMedGoogle Scholar
  19. 19.
    Fazel A, Li SC, Burton FR. Octreotide relaxes the hypertensive sphincter of Oddi: pathological and therapeutic implications. Am J Gastroenterol 2002; 97:612–616.CrossRefPubMedGoogle Scholar
  20. 20.
    Sostre S, Kalloo AN, Spiegler EJ, et al. A noninvasive test for sphincter of Oddi dysfunction in postcholecystectomy patients: the scintigraphic score. J Nucl Med 1992; 33:1216–1222.PubMedGoogle Scholar
  21. 21.
    Madacsy L, Middelfort HV, Matzen P, et al. Quantitative hepatobiliary scintigraphy and endoscopic sphincter of Oddi manometry in patients with suspected sphincter of Oddi dysfunction: assessment of flow-pressure relationship in the biliary tract. Eur J Gastroenterol Hepatol 2000; 12:777–786.PubMedGoogle Scholar
  22. 22.
    Rosenblatt M, Catalano MF, Alcocer E, Geenen JE. Comparison of sphincter of Oddi manometry, fatty meal sonography, and hepatobiliary scintigraphy in the diagnosis of sphincter of Oddi spasm. Gastrointest Endosc 2001; 54:697–704.CrossRefPubMedGoogle Scholar
  23. 23.
    Pineau BC, Knapple WL, Spicer KM, et al. Cholecystokinin-stimulated mebrofenin (Tc-99m-Choletec) hepatobiliary scintigraphy in asymptomatic postcholecystectomy individuals: assessment of specificity, interobserver reliability, and reproducibility. Am J Gastroenterol 2001; 96:3106–3109.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Gerbail T. Krishnamurthy
    • 1
    Email author
  • Shakuntala Krishnamurthy
    • 1
  • Randy D. Watson
    • 2
  1. 1.Department of Nuclear MedicineTuality Community HospitalHillsboroUSA
  2. 2.Department of GastroenterologyTuality Community HospitalHillsboroUSA

Personalised recommendations